4-formylaminoantipyrine,
4-Formylaminoantipyrine,
1672-58-8,
N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide,
Formamide, N-antipyrinyl-,
UNII-63DKU1M0XK,
(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide,
4-Formylamino Antipyrine,
NSC 60565,
63DKU1M0XK,
4-Formylaminophenazone,
N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)formamide,
N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide,
1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylformamide,
4-Formamidoantipyrine,
N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)carboxamide,
EINECS 216-808-3,
N-Antipyrinylformamide,
N-antipyrinyl formamide,
4-(Formylamino)antipyrine,
AC1L2IG2,
AC1Q6IH1,
Oprea1_056999,
Oprea1_347608,
AC1Q403I,
SCHEMBL6812409,
CHEBI:83526,
CTK7I1566,
KS-00000IYT,
DTXSID10168241,
WSJBSKRPKADYRQ-UHFFFAOYSA-N,
HMS1673G16,
ZINC301550,
ALBB-021702,
NSC60565,
5360AD,
MFCD00085457,
NSC-60565,
SBB097764,
STK993651,
AKOS000633307,
MCULE-4865850721,
WLN: T5NNVJ A1 BR& DMVH E1,
AJ-19081,
AK-63291,
BAS 01025526,
DS-15213,
FT-0648425,
ST50244241,
Z-0084,
AG-690/12869770,
W-109692,
4formylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one,
4-Formylaminoantipyrine, VETRANAL(TM), analytical standard,
Formamide,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-,
N-(2,3-2H-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide,
formamide, (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-,
Formamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-,
Metamizole impurity A, European Pharmacopoeia (EP) Reference Standard,
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-formamide,
4-Formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4-Formylaminophenazone),
4-formylaminoantipyrin,
Metamizole Impurity A,
C12H13N3O2,
CID72666,
AR-1J7061,
C12-H13-N3-O2,
CS-O-31126,
1703-90-8,